FHA
CBAY

Flagship Harbor Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Flagship Harbor Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed – – 2015
2019
Q4 		$0 Hold
100
– – ﹤0.01% 1987
2019
Q3 		$0 Hold
100
– – ﹤0.01% 2005
2019
Q2 		$0 Hold
100
– – ﹤0.01% 2012
2019
Q1 		$1K Hold
100
– – ﹤0.01% 1798
2018
Q4 		$0 Hold
100
– – ﹤0.01% 2147
2018
Q3 		$1K Hold
100
– – ﹤0.01% 2036
2018
Q2 		$1K Buy
+100
New +$1.25K ﹤0.01% 1983

Other funds holding CBAY

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return